Related Experiment Videos
Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy
L A Yannuzzi1, K B Freund, M Goldbaum
1Vitreous-Retina-Macula Consultants, New York, New York, USA. VRMNY@aol.com
Ophthalmology
|April 18, 2000
Summary
Distinguishing polypoidal choroidal vasculopathy (PCV) from central serous chorioretinopathy (CSC) can be challenging. Indocyanine green (ICG) angiography is crucial for accurate diagnosis, guiding appropriate treatment and prognosis for these distinct conditions.
Area of Science:
- Ophthalmology
- Medical Imaging
Background:
- Central serous chorioretinopathy (CSC) and polypoidal choroidal vasculopathy (PCV) are distinct retinal conditions.
- Differentiating these entities is crucial for appropriate management and prognosis.
Observation:
- A retrospective case series reviewed thirteen patients initially diagnosed with CSC but later confirmed to have PCV.
- Clinical and angiographic findings, including macular detachment, were analyzed.
Findings:
- Patients diagnosed with PCV exhibited exudative macular detachments due to polypoidal choroidal neovascularization.
- Fluorescein angiography showed variable signs, while indocyanine green (ICG) angiography definitively identified polypoidal lesions.
Implications:
- ICG angiography is essential for differentiating PCV from CSC, especially in cases with persistent exudation.
- Accurate diagnosis impacts understanding of risk factors, natural history, and visual outcomes.